Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Free Cash Flow (2021 - 2026)

Biohaven (BHVN) posted Free Cash Flow of -$149.9 million for Q1 2026, down 14.73% sequentially from -$130.7 million in Q4 2025, and up 9.46% YoY from -$137.0 million in Q1 2025.

Analysis

Biohaven (BHVN) Free Cash Flow (2021 - 2026) Analysis & Trends

Biohaven has reported Free Cash Flow for 6 years, with the latest figure at -$149.9 million in Q1 2026.

  • Quarterly Free Cash Flow rose 9.46% year-over-year to -$149.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$594.5 million (up 8.4% YoY) and the FY2025 annual result came in at -$610.2 million, down 4.03% from the prior year.
  • Free Cash Flow slipped to -$149.9 million in Q1 2026 per BHVN's latest filing, from -$130.7 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$45.0 million in Q2 2023 and troughed at -$170.8 million in Q4 2024.
  • A 5-year average of -$116.8 million and a median of -$115.4 million in 2023 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow soared 34.7% in 2023, then tumbled 279.54% in 2024.
  • Over 5 years, Free Cash Flow stood at -$75.7 million in 2022, then slumped by 52.37% to -$115.4 million in 2023, then sank by 48.06% to -$170.8 million in 2024, then grew by 23.49% to -$130.7 million in 2025, then declined by 14.73% to -$149.9 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$149.9 million, -$130.7 million, and -$145.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Biohaven 2.37 Bn 2.10 Bn - -85.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -85.55 Mn
Mar 31, 2026 -149.92 Mn
Dec 31, 2025 -130.67 Mn
Sep 30, 2025 -145.73 Mn
Jun 30, 2025 -168.17 Mn
Mar 31, 2025 -165.59 Mn
Dec 31, 2024 -170.79 Mn
Sep 30, 2024 -141.89 Mn
Jun 30, 2024 -170.75 Mn
Mar 31, 2024 -103.08 Mn
Dec 31, 2023 -115.35 Mn
Sep 30, 2023 -96.06 Mn
Jun 30, 2023 -44.99 Mn
Mar 31, 2023 -78.37 Mn
Dec 31, 2022 -75.71 Mn
Sep 30, 2022 -100.08 Mn
Jun 30, 2022 -68.89 Mn
Mar 31, 2022 -59.08 Mn
Dec 31, 2021 -33.26 Mn